Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
104 Cards in this Set
- Front
- Back
ideal psy drug should act directly on the --- mechanish of the ----- or ------ to cure or alleviate
|
pathogenetic
symptom disorder (but it's unknown) |
|
ideal psy drug should be effective -----
|
rapidly
sometimes not effective and rapid |
|
ideal psy drug should benefit most or all pts for who it's indicated
|
only works on 70% for antipsy
and 50% for antidepressants |
|
ideal psy drug should not allow --- to develop
show be ----- and lack potential for creating ----- |
tolerance
nonhabituating dependence have increased tolerance and addiction |
|
ideal psy drugs should have min ----- in the tx range and have low incidence of 2ndary ----
|
toxicity
se |
|
ideal psy drugs should not be ---- in overdose and be adaptable in both--- and ----
|
lethal
inpatients outpatients |
|
ideal psy drugs should not impaire any ---, ---, or --- fxs
|
cognitive
perceptual motor |
|
which drugs have the most se
|
MAOI
TCA TAP |
|
which drugs have the least SE
|
SSRI
NSRI NSSRI ATAP |
|
dx of schizophrenia:
at least 1 ---- symptom plus - or more of the other symptoms |
positive
1 |
|
how long must you have the symptom to be dxed w/ schizophrenia
|
over 6 months
|
|
dx of schizophrenia involoves no evidence of --- or --- disorder
|
drug induced
mood |
|
positive symptoms
|
hallucinations
delusiions disorganizede speech/formal thought disorder disorganized/bizarre/catatonic behavior |
|
neg symptoms
|
alogia
avolition/amotivational affective blunting anhedonia |
|
cognitive defects symptoms
|
tangentiality
incoherance looseness of associations neologisms |
|
domain of diorganized/bizarre/catatonic behavior
|
positive symptoms
|
|
domain of disorgainzed speech/formal thought disorder
|
positive
|
|
DA hypothesis of psy disorders
too much DA in the ------- |
mesolimbic
from NAC to VTA |
|
da hypothesis of psy disorders
too little DA in the ---- systme |
mesocortico system
vta to frontal cortex |
|
too little da inthe mesocortical system can lead to --- symtoms
|
mesocortico
|
|
sertonin hypothesis:
too much/little 5HT inhibiting ---- cortex |
too much 5ht
prefrontal this leads to an imbalance in DA |
|
glutamate hypothesis:
loss of --- receptors |
NMDA
|
|
neurodevelopment hypothesis:
abnormal --- development involved w/ neuronal ------ and ---- |
feta
migration connection |
|
pts lacking connections tend to have --- ventricles
|
larger
|
|
pt's might have neuro----
|
neurodegeneration
|
|
why do meds take a while to tx psy
|
cuz need to reconnect
|
|
the mesolimbic is the --- --- area to the --- ----, ----
|
ventral tegmental area
nucleus accumbens amygdala |
|
the mesolimbic is involved in ----, --- psychosis
|
addiction
amphetamine |
|
if the mesolimbic becomes hyperfunctional what occurs
|
pos symptoms
|
|
mesocortical is the --- ---- area to the --- ---
|
ventral tagmental area
frontal cortex |
|
mesocortical execute functio fothe brain due to --- feedback to Nac
|
inhibitory
|
|
mesocortical pathway may become hypofunctional which may lead to ----
|
neg symptoms
|
|
where the motor control
|
nigrostriatal pathway
|
|
nigrostriatal pathway is the basis of ------ se
|
motor-related
|
|
what's involved in endocrine fx
|
tuberoinfundibular
tuberhypophyseal |
|
the tuberoinfundibular and tuberohypophyseal are the basis for ---- related SE
|
prolactin
|
|
what usu inhibits prolactin
|
DA
so when blocked. .. increas in prolactin |
|
what can an increase in prolactin cause
|
menstrual irregularities
gynecomastia |
|
ctz is located in the --- ---
|
area posterna
|
|
t/f
block da can lead to emesis |
f
antiemetic effects |
|
how to avoid eps
|
slowly taper after 1 yr
|
|
drug tx works best for ---- episodes of --- symptoms
|
acute
positive |
|
which eps irreversible
|
tardive dyskinesia
|
|
the sedative action and the cognitive dysfunctions due to
|
anticholinergic
antihistminic effects |
|
if you block the 5HTA/C receptor what occurs
|
inhibitor of DA. . . less DA
|
|
high potency meds will have what type of se
|
parkinson's
cuz higher affinity for DA |
|
the low potency meds wil lhave have what type of SE
|
muscarinic
adrenergic histiminic other SE |
|
normal there's a balance btw DA and --- that prevents parkinson's
|
muscarinic
so when you decrease and the higher muscarinic will lead to parkinson se you'll also have to block the muscarinic to to restore balance |
|
w/ D2 like receptor subtype antagonism you decrease --- symptoms via decrease NAC DA signaling
|
positive
|
|
w/ D2 like receptor subtype antagonism you decrease positive symptoms via decrease --- DA signaling
|
NAC
|
|
how will the neg symptoms worsen
|
by decreaseing PFC signaling
|
|
se due to antagonism of d2-like
intially there's -------- |
parkinson like symtoms
|
|
d2 like antag leads to --- --- w/ prolonged tx
|
tardive dyskinesia
|
|
d2 like antag can lead to gyencomastia due to increased ---- due to -- blockade
|
prolactin
D2 |
|
alpha-1 antag can lead to these se
|
dizziness
postural hypotension relfex tachycardia |
|
antimuscarinic can lead to
--- vision --- mouth constipation --- retention |
blurry
dry urinary |
|
antimuscarinic can relieve/worsen intital parkinsonism, relieve/worsen tardive dyskinesia
|
relieve
worksen |
|
what can lead to sedation and weight gain
|
blocakge of histamine receptors
|
|
too much antagonist can lead to an ---- of receptors
|
upregulation
|
|
too much antagonist can also lead to
-----in 2nd messengers ---- metabolism of Da ----synthesis/release of DA |
increase
decrease increase |
|
major limiting factor for tx use of antipsychotics
|
eps
|
|
parkinson' like se
|
catatonia
motor rigiditiy tremor |
|
which 5HT leads to weight gain
|
combo of 2A and 2C
|
|
dystonia can lead to --- muscle contractions that cause ----- and uncontrolled movements of the face, neck and -----
|
involuntary
bizarre tongue |
|
severe restlessness and agitation
|
akathisia
|
|
when are movement continuous for tardive dyskinesia
|
during waking hrs
|
|
who's more prone to tardive dyskinsia
men or women |
women
|
|
how long can it take tardive dyskinesia to decrease
|
2-5 yrs
|
|
what can increase TD sensitivity
|
anticholinergics
L-dopa |
|
s/s of TD
|
chewing
licking movements tongue protrusions limb movements |
|
td possibly b/c:
continuous exposure to --- antagonist led to increased --- number or increased --- to DA |
DA
receptor sensitivity |
|
another theory of td
some d2 receptors cause --- and --- while others cause parkinsonism |
dyskinesias and dystonia
parkinsonism and akathisia |
|
td can be due to decreased striatal -- acitivity
|
GABA
|
|
abnormal d2/d- ration can cause td
|
d1
|
|
d1 agonists cause more TD if --- receptors blocked
|
D2
|
|
---- ---- decrease dose until symptoms decrease
|
drug holidays
may return more severe even at lower dose |
|
tx of td
--- or switch to an atypical antipsychotic |
d/c
lower but not zero (switching) |
|
what can help w/ reducing
|
cholinergic agonist
|
|
which receptors more specifically involved in eps
|
D2
|
|
atypical antipsychotics have -- to --- x less potent for --- and ---- se
|
eps
prolactin |
|
atypical antipsychotics have more efficacy towards --- and -- symptoms
|
negative
cognitive |
|
aytpical have less ---, ---- impairment, and ----
|
sedation
cognitive catalepsy |
|
atypical have less --- --- w/ prolonged use
|
td
|
|
se of atypical
|
weight gain
dm increased cholesterol heart probs |
|
why less sedation w/ atypical
|
cuz they are more selective
|
|
possible mech of atypical
limbic or cortical D- and D- receptors vs ----- D2 |
D3 and D4
striatal |
|
mech for atypical
blockade of --- ---- 5Ht-2 receptors |
frontal cortex
|
|
blockade of frontal cortex 5HT receptors stops --- inhibition of mesocortical ----
|
Serotonin
dopamine (decrease neg symptoms) |
|
which se occurs mainly at d2 receptors
|
akathisia
eps |
|
what % of D2 occupancy needed for tx w/ typical and atypical
|
typical: 70%
atypical: 20% |
|
dose response separation btw --- and --- effects is possible mechanism of atypical
|
therapeutic
motor |
|
atypical might need contribution from ---- occupancy
|
5HT2
|
|
se of atypical
|
weight gain
impaired glucose tolerance hyperlipidemia |
|
clozapine se
|
1% incidence of agranulocytosis
monitor wbc q week |
|
ziprasidone, sertindole, and thioridazine se
|
qt prolongation and risk of sudden death
binds to K channel subtype |
|
risperidone se
|
increased risk of stroke
some eps gynecomastia |
|
olanzapine se
|
increase risk of stroke
worst weight gain |
|
aripiprazole se
|
increase risk of stroke
|
|
s/s of malignant syndrome
|
catatonia
stupor fever unstable bp myglobinemia |
|
mech of malignant unknown but r/t --- receptor antagonism
|
DA
|
|
tx of malignant syndrome
|
stop tx and give
dantrolene bromocriptine |
|
which will have more malignant syndrome
|
typical
|
|
bromocripitne have ---activity
|
agonist
|
|
partial agonist restore transmission needed but block where needed. ..
|
balance
|